Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Authors: Elmar A. Joura, Sepp Leodolter, Mauricio Hernández‐Ávila, Cosette M. Wheeler, Gonzalo Pérez, Laura A. Koutsky, Suzanne M. Garland, Diane M. Harper, Grace Tang, Daron G. Ferris, Marc Steben, Ronald W. Jones, Janine T. Bryan, Frank J. Taddeo, Oliver Bautista, Mark T. Esser, Heather L. Sings, Micki Nelson, John W. Boslego, Carlos Sattler, Eliav Barr, Jorma Paavonen - The Lancet 2007 cited by 580